VITADX
VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.
VITADX
Industry:
Artificial Intelligence (AI) Biotechnology Oncology
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.vitadx.com
Total Employee:
11+
Status:
Active
Total Funding:
4.72 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Tag Manager Google Analytics LetsEncrypt Amazon SSL By Default Global Site Tag
Similar Organizations
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Biop AI
Biop AI is a company that deploys AI-based solutions and products for early-stage cancer diagnosis
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Current Advisors List
Current Employees Featured
Founder
Investors List
ODYSSEE VENTURE
ODYSSEE VENTURE investment in Venture Round - VitaDX
Caisse d’Epargne
Caisse d’Epargne investment in Debt Financing - VitaDX
BNP Paribas
BNP Paribas investment in Debt Financing - VitaDX
GO CAPITAL
GO CAPITAL investment in Venture Round - VitaDX
CIC Ouest
CIC Ouest investment in Debt Financing - VitaDX
Banque Populaire Grand-Ouest
Banque Populaire Grand-Ouest investment in Debt Financing - VitaDX
GO CAPITAL
GO CAPITAL investment in Seed Round - VitaDX
Auriga Partners
Auriga Partners investment in Seed Round - VitaDX
WILCO
WILCO investment in Pre Seed Round - VitaDX
Official Site Inspections
http://www.vitadx.com Semrush global rank: 11.72 M Semrush visits lastest month: 150
- Host name: ec2-15-188-22-137.eu-west-3.compute.amazonaws.com
- IP address: 15.188.22.137
- Location: Paris France
- Latitude: 48.8607
- Longitude: 2.3281
- Timezone: Europe/Paris
- Postal: 75001
More informations about "VitaDX"
Company Specialized in AI & Image Processing | VitaDx
VitaDX, a deep tech based in Rennes and Paris, develops and markets cancer diagnostic solutions combining artificial intelligence and image processing applied to cytology. Its first solution, VisioCyt® Bladder, allows an early detection of …See details»
VitaDx | Deep Tech en Santé - IA & Cytologie Digitale
VitaDX a été créée en avril 2015 afin de valoriser une technologie brevetée, combinant l’imagerie et l’intelligence artificielle. Cette technologie, basée sur des travaux de recherche menés par …See details»
VitaDX - Crunchbase Company Profile & Funding
VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, …See details»
Strategic appointments for VitaDX with the nomination of Hilja …
Rennes and Paris, September 17 th, 2024 - VitaDX, an innovative player in the French deep tech sector, announces strategic changes to its organization with the appointment of Hilja Ibert and …See details»
VitaDX - LinkedIn
VitaDX develops software solutions to detect cancer using image processing and artificial intelligence. For more information check out our website: www.vitadx.com Follow us on twitter...See details»
VitaDX Company Profile 2024: Valuation, Funding & Investors
Developer of medical devices designed to identify the early stage of bladder cancer in patients.See details»
Allan Rodriguez - CEO at VitaDX - The Org
Allan Rodriguez has a diverse work experience spanning various roles and industries. Allan began their career as an Innovation Strategy Consultant in Life Sciences at Actemis in 2007, …See details»
VITADX INTERNATIONAL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VITADX INTERNATIONAL of RENNES, BRETAGNE. Get the latest business insights from Dun & …See details»
VitaDX International - VentureRadar
VitaDX is a startup applying artificial intelligence to the healthcare sector and more specifically to the early diagnosis of cancer by using fluorescence imaging to its first product; VisioCyt®; …See details»
VitaDX | EU-Startups
VitaDX is currently developing a medical software solution for early diagnosis of bladder cancer using fluorescence imaging and machine learning. You're a corporate or investor and looking for startups that are innovating in the same …See details»
Investors | VitaDx
In 2019-2020, VitaDX raised €5 million from the historical venture capital funds Go Capital, Auriga Partners, FFBB Management and also from a new fund Odyssee Venture to support the …See details»
Women Revolutionizing: Life Sciences - VitaDx | Invenia Group
Aug 11, 2023 · Our aim is to inspire the next generation of women, by giving an insight into what attracted individuals to this career, their experiences and words of advice for those either …See details»
Vitadx raising $8.3M to roll out system for detecting bladder cancer
Nov 21, 2022 · Vitadx SA is preparing to close a new $8.3 million funding round, to ramp European distribution of its automated software platform for early detection of bladder cancer. …See details»
VitaDX révolutionne le diagnostic du cancer de la vessie - SATT …
May 17, 2022 · Sa technologie, développée avec l’ONERA, combine imagerie et intelligence artificielle pour un diagnostic précoce du cancer de la vessie, 5 e cancer le plus fréquent en …See details»
VitaDX facilite la détection les cancers de la vessie grâce à l ...
Allan Rodriguez, le directeur général de VitaDX, revient sur les projets de la société rennaise. Détecter de manière plus précoce et efficace le cancer de la vessie, cinquième cause de …See details»
Vanguard Information Technology Idx Adm VITAX - Morningstar
Morningstar's style-agnostic investment process evaluation looks for strategies that should be able to outperform their Morningstar Category peers on a risk-adjusted basis over time. …See details»
VitaDx | News
Multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder… VitaDX is proud to announce its …See details»
VITAX Vanguard Information Technology Index Fund Admiral Shares
Vanguard Information Technology Index Fund seeks to track the investment performance of the MSCI US Investable Market Information Technology 25/50 Index, a benchmark of large-, mid-, …See details»
VITAX Mutual Fund Stock Price & Overview - Stock Analysis
5 days ago · Get the latest Vanguard Information Technology Index Fund Admiral Shares (VITAX) stock price quote with financials, statistics, dividends, charts and more.See details»
News - VitaDx
Dec 18, 2023 · Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancerSee details»